-
Germline Genetics of Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
Study
phs002962
-
California Teachers Study (CTS): Whole Genome Sequences From Under-Represented Populations
Study
phs002918
-
Cancer-Restricted Cryptic Antigens Are Targets for T Cell Recognition
Study
phs003887
-
Understanding Determinants of Racial Disparities in Lung Cancer Incidence
Study
phs003789
-
Prediction of Resistance and Sensitivity to HER2 Targeted Therapy in the Neoadjuvant Setting
Study
phs003275
-
Genetic Studies of Homologous Recombination Deficiency in Hispanic Gastric Cancer
Study
phs003251
-
Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-Based Cohorts (LEANORA)
Study
phs003770
-
Integrated Somatic and Germline Molecular Properties Dictating Biological and Clinical Phenotypes in Cancer
Study
phs003438
-
Immune-Related Adverse Events after Immune Checkpoint Blockade-Based Therapy are Associated with Improved Survival in Advanced Sarcoma
Study
phs003284
-
Cancer Moonshot Biobank
Study
phs002192
-
DAC for "Establishment and characterization of circulating tumor cells-derived organoids from metastatic breast cancer patients."
Dac
EGAC50000000371
-
Yale Policy for head and neck cancer and HPV clinical trials
Dac
EGAC50000000403
-
CANCAP03 Data Access Committee
Dac
EGAC50000000508
-
Randomized Phase II 2 x 2 Factorial Trial of the Addition of Carboplatin +/- Bevacizumab to Neoadjuvant Weekly Paclitaxel Followed by Dose-Dense AC in Hormone Receptor-Poor/HER2-Negative Resectable Breast Cancer: DNA Sequencing
Study
phs003801
-
DAC for "Copy number variations and fragmentation features in cell-free DNA predict response in advanced non-small cell lung cancer patients under anti-PD-(L)1 therapy"
Dac
EGAC50000000308
-
Proteogenomic Analysis of CALGB40601 (ALLIANCE) a Neoadjuvant Phase III HER2-Positive Breast Cancer Trial
Study
phs003576
-
DNA Methylation in Prostate Tumor and Paired Benign Tissue for African and European Ancestry Men
Study
phs003516
-
Atezolizumab Plus Personalized Neoantigen Vaccination in Patients with Urothelial Cancer: a Phase 1 Trial
Study
phs003922
-
Timing and trajectory of BCR-ABL1 driven chronic myeloid leukaemia
Dataset
EGAD00001015473
-
The data access committee for Genome-wide analyses of cell-free DNA for therapeutic monitoring of patients with pancreatic cancer
Dac
EGAC50000000588
-
A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer
Study
phs003294
-
Durvalumab Plus Tremelimumab Alone or in Combination with Low-Dose or Hypofractionated Radiotherapy in Metastatic Non-Small-Cell Lung Cancer Refractory to Previous PD(L)-1 Therapy: an Open-Label, Multicentre, Randomised, Phase 2 Trial
Study
phs003295
-
Sequencing of 3D Organoids Derived From Colorectal Cancer Patients
Study
phs003965
-
Childhood Cancer Data Initiative (CCDI): Comprehensive Genomic Sequencing of Pediatric Cancer Cases (CMRI/KUCC)
Study
phs002529
-
DirectHRD Enables Sensitive Scar-Based Classification of Homologous Recombination Deficiency (HRD)
Study
phs003760